Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

We have the budget/expenses for next year around $8.2 million

In light of the ongoing pandemic and drug development environment, we have prioritized development of Brilacidin for COVID-19, including working with one of our academic partners to seek a federal grant for research work and preparing for a planned Phase 2 clinical trial of Brilacidin for COVID-19. We are targeting the fourth quarter of 2020 to initiate this clinical trial, while simultaneously planning for a Phase 2 clinical trial of oral Brilacidin for UC in the first half of 2021